Skip to main content
Tellgen Corporation logo

Tellgen Corporation — Investor Relations & Filings

Ticker · 300642 ISIN · CNE100002P42 LEI · 30030027IMY7UJOVB424 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,381 across all filing types
Latest filing 2026-05-15 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 300642

About Tellgen Corporation

https://www.tellgen.com

Tellgen Corporation specializes in the development, manufacture, and distribution of in vitro diagnostic (IVD) products. The company focuses on high-throughput multiplex testing solutions, utilizing advanced technologies such as liquid chip platforms and multiplex PCR. Its product portfolio encompasses a wide range of clinical applications, including oncology screening, infectious disease detection, cardiovascular health assessment, and genetic testing. Tellgen is recognized for its proprietary multiplexing technology, which allows for the simultaneous detection of multiple biomarkers in a single sample, enhancing diagnostic efficiency and accuracy. The company provides comprehensive diagnostic systems, including reagents and automated instrumentation, to clinical laboratories and healthcare institutions. By integrating molecular and immunodiagnostic methodologies, Tellgen supports early disease detection and personalized medicine initiatives.

Recent filings

Filing Released Lang Actions
2025年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 97% confidence The document is titled as a 2025 shareholder meeting resolutions announcement (“2025年度股东会决议公告”) and provides detailed voting results for ten proposals, including vote counts and percentages. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-15 Chinese
上海市光大律师事务所关于上海透景生命科技股份有限公司2025年度股东会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a legal opinion letter on the convening, procedures and qualification of attendees for Shanghai Toujing Life Technology’s 2025 annual shareholders meeting, and it provides detailed vote counts and outcomes for each agenda item. This matches the definition of “Declaration of Voting Results & Voting Rights Announcements (Code: DVA),” which covers official results from shareholder votes at general meetings.
2026-05-15 Chinese
2026年一季度报告
Interim / Quarterly Report Q1 2026
2026-04-24 Chinese
公司2025年度非经营性资金占用及其他关联资金往来情况汇总表
Regulatory Filings Classification · 62% confidence The document is a standalone summary table of non-operating funds occupancy and other related-party fund transactions for the 2025 fiscal year, approved by the board. It does not constitute a full Annual Report (10-K), nor is it an announcement of a report. It is a specialized disclosure that does not fit any other specific category, so it falls into the general regulatory filings fallback category.
2026-04-24 Chinese
2025年年度审计报告
Regulatory Filings
2026-04-24 Chinese
关于提请股东会授权董事会办理小额快速融资相关事宜的公告
Share Issue/Capital Change Classification · 86% confidence The document is an official announcement of a proposed small‐amount quick financing via a private placement of new A‐shares, detailing the authorization sought at the upcoming shareholders’ meeting. This falls under announcements of new share issue/capital changes rather than a full report or regulatory filing. Therefore, it is classified as Share Issue/Capital Change (SHA).
2026-04-24 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.